Article

Addition Technology forms foundation for keratoconus sufferers

Addition Technology Inc. has established the Foundation for Keratoconus Care to provide financial support to patients with keratoconus who may not have the means to acquire micro-thin prescription inserts (Intacs).

The non-profit foundation will also provide a patient-assistance program to counsel patients on clinical options, including the selection of primary and surgical eye-care practices, as well as support clinical research for the disease through grants.

Michael R. Southard has been appointed executive director of the foundation. As an eye-care executive with more than 30 years’ experience, Southard most recently worked for Wesley Jessen and CIBA Vision.

Funding for the foundation will be provided by public and private sources. Addition Technology will contribute a percentage of sales from the micro-thin prescription inserts to the foundation. For more information, visit www.keratoconuscare.org.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.